After approving Covishield and Covaxin vaccines, the government has approved the Russian Sputnik-V vaccine on Monday.

Last week, Dr Reddy’s Laboratories had sought the government’s approval for the Sputnik-V vaccine for use in the country. The Hyderabad-based pharma major partnered with RDIF or The Russian Direct Investment Fund in September last year for conducting the clinical trials of Sputnik-V in the country.

Sputnik-V reportedly has an efficacy of 91.6%. Its Phase-III of clinical trials is being conducted in India, Venezuela, Belarus, and the UAE.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!